Glutaminyl Cyclase, Diseases, and Development of Glutaminyl

Discovery of potent indazole-based human glutaminyl cyclase (QC) inhibitors as Anti-Alzheimer's disease agents - ScienceDirect

A glutaminyl cyclase-catalyzed α-synuclein modification identified in human synucleinopathies

Discovery of Conformationally Restricted Human Glutaminyl Cyclase Inhibitors as Potent Anti-Alzheimer's Agents by Structure-Based Design

Frontiers Development and evolution of human glutaminyl cyclase inhibitors (QCIs): an alternative promising approach for disease-modifying treatment of Alzheimer's disease

Computational Methods for the Design and Development of Glutaminyl Cyclase Inhibitors in Alzheimer's Disease

Upregulation of Glutaminyl Cyclase Contributes to ERS-Induced Apoptosis in PC12 Cells

IsoQC (QPCTL) knock-out mice suggest differential substrate conversion by glutaminyl cyclase isoenzymes

Glutaminyl cyclases unfold glutamyl cyclase activity under mild acid conditions - ScienceDirect

Molecules, Free Full-Text

Crystal structures of human glutaminyl cyclase, an enzyme responsible for protein N-terminal pyroglutamate formation

Upregulation of Glutaminyl Cyclase Contributes to ERS-Induced Apoptosis in PC12 Cells

Glutaminyl Cyclase, Diseases, and Development of Glutaminyl Cyclase Inhibitors

a Glutaminyl cyclase activity (mU/L): change from baseline at end of